S100A12 and rheumatoid arthritis: Elevated levels of S100A8, S100A9, and S100A12 have been identified in the synovial fluid and serum of RA patients, highlighting their role as biomarkers for inflammation, and their potential as diagnostic and prognostic indicators of disease activity and progression [75,76].